CHARLES SCHWAB INVESTMENT MANAGEMENT INC - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 40 filers reported holding EVELO BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$50,465
-23.5%
31,3450.0%0.00%
Q3 2022$66,000
-73.8%
31,345
-73.7%
0.00%
Q2 2022$252,000
-63.7%
119,267
-41.8%
0.00%
Q1 2022$695,000
-43.3%
205,003
+1.7%
0.00%
Q4 2021$1,225,000
-10.6%
201,659
+3.6%
0.00%
Q3 2021$1,371,000
-48.1%
194,685
+1.3%
0.00%
-100.0%
Q2 2021$2,641,000
+44.8%
192,181
+12.8%
0.00%0.0%
Q1 2021$1,824,000
+13.8%
170,392
+28.5%
0.00%0.0%
Q4 2020$1,603,000
+110.6%
132,560
-8.1%
0.00%
Q3 2020$761,000
+111.4%
144,274
+96.6%
0.00%
Q2 2020$360,000
+40.1%
73,390
+7.6%
0.00%
Q1 2020$257,000
-5.9%
68,230
+1.5%
0.00%
Q4 2019$273,000
-41.3%
67,225
-11.6%
0.00%
Q3 2019$465,000
+17.1%
76,067
+72.5%
0.00%
Q2 2019$397,000
+20.7%
44,103
+7.5%
0.00%
Q1 2019$329,000
-37.7%
41,015
+1.2%
0.00%
Q4 2018$528,000
+80.8%
40,541
+69.2%
0.00%
Q3 2018$292,000
+9.4%
23,967
+6.1%
0.00%
Q2 2018$267,00022,5800.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders